 |
The Trust is grateful to the following for their contributions.
Many private donors * Fujisawa Corporation
* Oxford Glycosciences *
F2G Ltd * Chronic Granulomatous Disorder
Research trust * Aventis *
Janssen Research Foundation * Roche *
Schering Plough Corporation * The Liposome
Company * Merck Inc *
Imedex Inc * Bristol Myers Squibb *
Aronex Ltd * Vestar Inc *
Eli Lilly * BioMerieux *
Alza Corporation * Pfizer Inc *
Zeneca Pharmaceuticals * Novartis *
Phairson Ltd * GlaxoWellcome *
The Gossett Trust * The Clear Group *
British Medical Association * Basilea * Valeant * Orthobiotech *
The FRT holds a small minority shareholding in F2G Ltd,
an antifungal drug discovery and development company established in
late 1998. FRT received the shares in 2001 in return for assistance
provided in the establishment of F2G.